Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice

Journal of Nephrology

Volumn 16, Issue 6, 2003, Pages 841-849

  Lioa, Jie ^a   Kobayashi, Michimasa ^a   Kanamuru, Yutaka ^a   Nakamura, Shinji ^a   Makita, Yuichiro ^a   Funabiki, Kazuhiko ^a   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ARB; Candesartan; Diabetic nephopathy; KK Ta mice; Smad7; TGF

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; COLLAGEN TYPE 4; DRUG VEHICLE; GLUCOSE; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CREATININE; DNA BINDING PROTEIN; SMAD7 PROTEIN, MOUSE; TETRAZOLE DERIVATIVE; TGFB1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL NUCLEUS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOSE RESPONSE; EXTRACELLULAR MATRIX; GLOMERULUS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; KIDNEY TUBULE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; ALBUMINURIA; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BLOOD PRESSURE; DRUG EFFECT; MESANGIUM; METABOLISM; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; URINE;

ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BLOOD GLUCOSE; BLOOD PRESSURE; COLLAGEN TYPE IV; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MICE; MICE, INBRED BALB C; MICE, OBESE; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TETRAZOLES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 1642568700     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993; 22: 7366-74.
2. Gilbert RE, Cox A, Dziadek M, Cooper ME, Jerums G. Extracellular matrix and its interactions in the diabetic kidney: A molecular biological approach. J Diabet Complications 1995; 9: 252-4.
3. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD. The effects of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
4. Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy. Kidney Int 2000; 57: 601-6.
5. Kurokawa K. Effects of candesartan on the proteinuria of chronic glomerulonephritis. J Hum Hypertens 1999; 13 (suppl 1): S57-60.
6. Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2) 27 rat. Kidney Int 2000; 57: 1882-94.
7. Rocco M, Chen Y, Goldfarb S, Riyadh FN. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 1992; 41: 107-14.
8. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN. Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 2000; 11: 2222-30.
9. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996; 49: 461-9.
10. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K. Quantification of glomerular TGF-beta1 mRNA in patients with diabetes mellitus. Kidney Int 1996; 49: 1120-6.
11. Park IS, Kiyomoto H, Abboud SL, Abboud HE. Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 1997; 46: 473-80.
12. Derynck R, Zhang Y, Feng XH. Smads: Transcriptional activators of TGF-beta responses. Cell 1998; 95: 737-40.
13. Bottinger EP, Miao J, Schiffer M, Bitzer M, Roberts IS. Transforming growth factor beta signal transduction in the kidney. Kidney Blood Press Res 1998; 21: 259-61.
14. Huang HC, Preisig PA. G1 kinases and transforming growth factor-β signaling are associated with a growth pattern switch in diabetes-induced renal growth. Kidney Int 2000; 58: 162-72.
15. Taketomi S, Fujita T, Yokono K. Insulin receptor and postbinding defects in KK mouse adipocytes and improvement by ciglitazone. Diabetes Res Clin Pract 1988; 13: 125-34.
16. Ikeda H. KK mouse. Diabetes Res Clin Pract 1994; 24 (suppl): S313-6.
17. Shike T, Hirose S, Kobayashi M, Funabiki K, Shirai T, Tomino Y. Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Diabetes 2001; 50: 1943-8.
18. Mackenzie HS, Troy JL, Rennke HG, Brenner BM. TCV116 prevents progressive renal injury in rats with extensive renal mass ablation. J Hypertens 1994; 12 (suppl XX): S11-6.
19. Liao J, Hayashi K, Horikoshi S, Ushijima H, Kimura J, Tomino Y. Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice. Nephron 2001; 89: 194-200.
20. Hong SW, Isono M, Chen S, Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the smad signaling pathway in the db/db mouse. Am J Pathol 2001, 158: 1653-63.
21. Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-30.
22. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G. Nephrin expression is reduced in human diabetic nephropathy. Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023-30.
23. Uehara Y, Hirawa N, Kawabata Y, Numabe A, Gomi T, Ikeda T, Omata M. Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolism in genetic rat model of non-insulin-dependent diabetes mellitus. Am J Hypertens 1999; 12: 21-7.
24. Iijima T, Suzuki S, Sekizuka K, Hishiki T, Yagame M, Jinde K, Saotome N, Suzuki D, Sakai H, Tomino Y. Follow-up study on type IV collagen in patients with early stage diabetic nephropathy. J Clin Lab Anal 1998; 12: 378-82.
25. Takizawa H, Satoh T, Kurusu A, Hishiki T, Shike T, Gohda T, Maeda A, Makita Y, Suzuki S, Fukui M, Tomino Y. Increase of urinary type IV collagen in normoalbuminuric patients with impaired glucose tolerance. Nephron 1998; 79: 474-5.
26. Tomino Y, Suzuki S, Azushima C, Shou I, Iijima T, Yagame M, Wang LN, Chen HC, Lai KN, Tan SY, Kim MJ. Asian multicenter trails on urinary type IV collagen in patients with diabetic nephropathy. J Clin Lab Anal 2001; 15: 188-92.
27. Han DC, Isono M, Hoffman BB, Ziyadeh FN. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-β. J Am Soc Nephrol 1999; 10: 1891-9.
28. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994; 93: 536-42.
29. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN. Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 2000; 11: 2222-30.
30. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE. Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int 1994; 45: 177-84.
31. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-7.
32. Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin II blockade decreases TGF-β1 and matrix protein in cyclosporine nephropathy. Kidney Int 1997; 52: 660-73.
33. Sun Y, Zhang JQ, Zhang J, Ramires FJ. Angiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J Mol Cell Cardiol 1998; 30: 1559-69.
34. Kanamaru Y, Nakao A, Mamura M, Suzuki Y, Shirato I, Okumura K, Tomino Y, Ra C. Blockade of TGF-beta signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 2001; 166: 2818-23.
35. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-16.
36. Uchida K, Nitta K, Kobayashi H, Kawachi H, Shimizu F, Yumura W, Nihei H. Localization of Smad6 and Smad7 in the rat kidney and their regulated expression in the anti-Thy-1 nephritis. Mol Cell Biol Res Commun 2000; 4: 98-105.